an טיפול בהפרעת קשב וטיקים ד" ר אריה אשכנזיAmerican Board of Psychiatry and Neurology נוירולוג ילדים סגן מנהלת המכון להתפתחות הילד בי" ח לילדים ע" ש ספרא בי" ח תל השומר
an
טיפול בהפרעת קשב
וטיקים
ר אריה אשכנזי"ד American Board of Psychiatry
and Neurology
נוירולוג ילדים סגן מנהלת המכון להתפתחות הילד
ש ספרא"ח לילדים ע"בי ח תל השומר"בי
טיפול בהפרעת קשב וטיקים דר אריה אשכנזי
נוירולוג ילדים
סגן מנהלת המכון להתפתחות הילד
מרכז רפואי עש שיבא–ח עש ספרא "בי
Faculty Disclosure Arie Ashkenasi MD
Janssen
Novartis
Medison
Pfizer
comorbidities
A.Language and Learning Disability (10-
15%)1.Usually less hyperactive and more
inattentive
B. Tourette's Syndrome (70% with tics
have ADHD)
C. Oppositional Defiant Disorder (35-65%
of ADHD patients)
D. Conduct Disorder (10-20% of ADHD
patients)
E. Major Depression (20% of ADHD
patients)
F. Anxiety Disorder (25% of ADHD
patients)
G. Substance Abuse (20-40% of ADHD
patients
What is a tic?
A “tic” is a sudden, rapid, recurrent, non-rhythmic,
stereotyped motor movement or vocalization
A tic may be simple (involving only a few muscles or
simple sounds) or complex (involving multiple groups of
muscles recruited in orchestrated bouts or words or
sentences)
TIC
Motor Tics (Simple)
Generally lasting less than several hundred milliseconds
Examples include:
eye blinking
nose wrinkling
neck jerking
shoulder shrugging
facial grimacing
abdominal tensing
Motor Tics (Complex)
Longer in duration than simple tics; usually lasting seconds or longer
Examples include: hand gestures
jumping, touching, pressing, or stomping
facial contortions
repeatedly smelling an object
squatting and/or deep knee bends
retracing steps and/or twirling when walking
assuming and holding unusual positions (including “dystonic” tics, such as holding the neck in a particular tensed position)
Copropraxia & Echopraxia
Both are considered complex motor tics
Copopraxia = a sudden, tic-like vulgar, sexual, or
obscene gesture
Echopraxia = a mirror phenomena, such as involuntary,
spontaneous imitation of someone else’s movements
Vocal Tics (Simple) Meaningless brief sounds
Examples include:
Throat clearing
Grunting
Sniffing
Snorting
Chirping
Vocal Tics (Simple) Meaningless brief sounds
Examples include:
Throat clearing
Grunting
Sniffing
Snorting
Chirping
Vocal Tics (Complex)
More clearly involve speech and language
Examples include:
sudden, spontaneous expression of single words or phrases
speech blocking
sudden and meaningless changes in pitch, emphasis, or
volume of speech;
The “Lalias”
All are considered complex vocal tics
Palilalia = repeating one’s own sounds or words
Echolalia = repeating the last heard sound, word,
or phrase
Coprolalia = the sudden, inappropriate expression
of a socially unacceptable word or phrase that may
include obscenities as well as specific ethnic,
racial, or religious slurs (found in fewer than 10%
of individuals with tic disorders)
Brain Stem
MESENCEPHALON
PONS
MEDULLARaphe nuclei(serotonin)
Substantia nigrategmentum(dopamine)
Locus ceruleus(norepinephrine)
to cerebellum
to cord
to diencephalon and
cerebrum
Basal ganglia
Nucleus
accumbens
Substantia
nigra
Ventral
tegmental area
Hypothalamus
Dopamine Pathways
Treatments: Psychosocial Education
Patient, family, and school
Counseling for family and patient
Relaxation therapy
Supportive therapy
Habit Reversal Therapy
Non Stimulants
Atomoxetine
Clonidine
Guanfacine
TCAs
Selective Norepinephrine Reuptake Inhibition:
Atomoxetine
• Potent inhibitor of presynaptic NEtransporter (reuptake pump)
• Minimal affinity for other noradrenergicreceptors or for other neurotransmittertransporters or receptors
Michelson et al. Pediatrics 2001;108:e83.
Biederman and Spencer. Biol Psychiatry 1999;46:1234.
Atomoxetine in ADHD
• Clinical effect similar to more NE-selective TCAs (eg, imipramine) withoutthe plethora of TCA-mediated adverseeffects
• Mechanism of action in ADHD is veryspecific to adrenergic system with nodirect effects on dopaminergic system
Michelson et al. Pediatrics 2001;108:e83.
Biederman and Spencer. Biol Psychiatry 1999;46:1234.
Clonidine, Guanfacine
• Efficacy of clonidine and guanfacine go along with theNE theory of deficit in ADHD
• Clonidine is an alpha 2 receptor agonist / guanfacinemore selective at alpha 2a
• Both presynaptic and postsynaptic receptors areinvolved– Stimulation of presynaptic receptors “dampens-down” the
locus ceruleus
– Stimulation of the alpha 2a receptors makes postsynapticneurons more responsive to specific inputs
Biederman and Spencer. Biol Psychiatry 1999;46:1234.
Excitatory signal
a2A receptor
NE
Ion channel
Reuptake transporter
Postsynaptic neuron
NE presynaptic terminal
Wang M, et al. Cell. 2007;129:397-410.
Transmission of Neuronal Signal
is Modulated by the a2A Receptor
TCAs
• Therapeutic effect mediated by 5HT and
NE reuptake blockade
– Desipramine, imipramine (used in ADHD)
more selective for NE reuptake blockade
• Adverse effects mediated by histamine,
muscarinic cholinergic, and alpha-
adrenergic receptor actions
Biederman and Spencer. Biol Psychiatry 1999;46:1234.
Antipsychotic Treatment Historically high potency first generation antipsychotics
Pimozide (Orap) best studied
Haloperidol
Severe side effects has led to search for alternative 2nd
generation antipsychotics
Risperidone- Aripiperazole
ADHD
Stimulant Medications
Of pharmacologic options available for
ADHD, stimulant medications are the:
Most studied
Most commonly used
Most effective
First-line agents for treatment
Spencer T et al. J Am Acad Child Adolesc Psychiatry. 1996;35:409-432; Dulcan M et al, for the Work Group on Quality Issues of the American
Academy of Child and Adolescent Psychiatry.
J Am Acad Child Adolesc Psychiatry. 1997;36:85S-121S; Greenhill LL et al, for the Work Group on Quality Issues of the American Academy of
Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 2002;41:26S-49S.
Stimulants Found to
Improve ADHD
Inattention
Impulsivity
Hyperactivity
Compliance
Impulsive aggression
Social interactions
Academic efficiency
Academic accuracy
AND
Spencer T et al. J Am Acad Child Adolesc Psychiatry. 1996;35:409-432; Dulcan M et al, for the Work Group on Quality Issues of the
American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36:85S-121S;
Greenhill LL et al, for the Work Group on Quality Issues of the American Academy of Child and Adolescent Psychiatry. J Am Acad Child
Adolesc Psychiatry. 2002;41:26S-49S; Zametkin AJ, Ernst M. N Engl J Med. 1999;340:40-46.
Core Symptoms
Stimulant dosing
No parameter predicts optimal stimulant dose or timing.
Not weight
Not age
Not gender
Not severity of illness
Each person must have the dose titrated to their
individual needs and duration of dose.
The best dose is that which leads to optimal effects
minimal side effects.
American Academy of Pediatrics clinical practice guideline. Pediatrics 2001:108:1033
v v Storage
vesicle
DA Transporter
Cytoplasmic DA
Methylphenidate
Presynaptic Neuron
Synapse
Probable Mechanism of Action
of Methylphenidate
Wilens T, Spencer TJ. Handbook of Substance Abuse: Neurobehavioral Pharmacology. 1998;501-513.
STIMULANTS:
METHYLYPHENIDATE
SHORT ACTING: Ritalin, Focalin (Dexmethlyphenidate)
INTERMEDIATE ACTING:, Ritalin LA
LONG ACTING: Concerta. Focalin XR. Daytrana
AMPHETAMINE
SHORT ACTING:,, Adderall (Mixed Salt)’Attent
LONG ACTING: Adderall XR .Vyvanse
AACAP Clinical Practice Guidelines. J Am Acad Child Adolesc Psychiatry. 1997;36(suppl):85S-121S.
Controversies: growth deficits, tic exacerbation, seizures, abuse
(Effects occurring in >5% of patients and >placebo)
Stimulants: Potential Side Effects
Appetite loss,
abdominal pain
Insomnia
Nervousness
Before Operation During Operation
Water
Water Push
Compartment
Drug
Compartment #2
Drug
Compartment #1
Orifice/Exit Port
Drug
Overcoat
Rate-
Controlled
Membrane
Methylphenidate HCI (Concerta®) Extended-Release
Tablets: Trilayer
Capsule-Shaped Tablets
Concerta® (methylphenidate HCl) extended-release tablets [package insert]. Mountain View, Calif: Alza
Corporation; 2006; Greenhill LL et al, for the Work Group on Quality Issues of the American Academy of
Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 2002;41:26S-49S;
Ritalin® LA: Extended-release Delivery via
SODAS™ Technology
SODAS™ is a trademark of Elan Corporation, PLC
H
N
H
H
Ph CH3OOC
2’
2
D (+) Methylphenidate
Dexmethylphenidate
H
H
H
Ph COOCH3
2’
2
l (-) Methylphenidate
N
Focalin: A Refined Form of Ritalin®
Chemical Structure of Vyvanse
Vyvanse is a prodrug that is therapeutically inactive until it
is converted to active d-amphetamine in the body
l-lysine
H N 2
O
OH
NH 2
+
d-amphetamine
(active)
H N 2
CH 3
Lisdexamfetamine
(Prodrug)
H N 2
O
N H
NH 2
CH 3
Site of cleavage
Rate-limited
Hydrolysis